Skip to main content

Table 21 (abstract A35). Outcomes suitable for meta-analysis

From: ESICM LIVES 2016: part one

Outcome

Trials

Participants

Effect estimate

Requirement for allogeneic RBC transfusion

5

613

RR 0.88 (95% CI 0.74 - 1.06, p=0.18)

Mean number of RBC units transfused

2

183

MD -2.06 units (95% CI -8.24 - 4.12, p=0.51)

Mean Hb (g/dL) at short-term follow-up

3

242

MD -0.25 g/dL; 95% CI -0.79 - 0.28, p=0.35

Mean Hb (g/dL) at mid-term follow-up

3

238

MD 0.21 g/dL; 95% CI -0.13-0.55, p=0.23

Mortality

4

454

RR 1.04 (95% CI 0.43 - 2.52, p=0.92)

Infection

2

347

RR 0.89 (95% CI 0.74 - 1.08, p=0.23)

Mean ferritin (ng/ml) at short-term follow-up

3

241

MD 193.61 ng/ml (95% CI -122.39 - 509.61, p=0.23)

Mean ferritin (ng/ml) at mid-term follow-up

3

235

MD 358.79 ng/ml (95% CI 169.85 - 547.74, p=0.0002)